investorscraft@gmail.com

Intrinsic ValueTruBridge, Inc. (TBRG)

Previous Close$20.09
Intrinsic Value
Upside potential
Previous Close
$20.09

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

TruBridge, Inc. operates in the healthcare technology sector, providing revenue cycle management, electronic health record (EHR) solutions, and business analytics primarily to rural and community healthcare providers. The company’s core revenue model is subscription-based, supplemented by professional services and support fees, ensuring recurring income streams. TruBridge differentiates itself by focusing on underserved healthcare markets, offering tailored solutions that address the unique challenges of smaller providers, such as regulatory compliance and operational efficiency. The company competes in a fragmented industry dominated by larger players but maintains a niche position by emphasizing customer service and localized expertise. Its market positioning is further strengthened by long-term client relationships and a reputation for reliability in critical healthcare IT functions. TruBridge’s ability to integrate financial and clinical workflows provides a competitive edge, though it faces pressure from consolidation trends and evolving technology demands in the broader healthcare IT landscape.

Revenue Profitability And Efficiency

TruBridge reported revenue of $342.6 million for FY 2024, reflecting its steady demand in the healthcare IT space. However, net income was negative at -$20.4 million, with diluted EPS of -$1.38, indicating profitability challenges. Operating cash flow of $32.1 million suggests underlying operational efficiency, though capital expenditures were modest at -$1.6 million, signaling limited reinvestment in growth initiatives.

Earnings Power And Capital Efficiency

The company’s negative earnings highlight pressures on margins, likely due to competitive pricing or elevated operating costs. Operating cash flow generation demonstrates some earnings power, but the net loss raises questions about capital allocation. With minimal capex, TruBridge appears to prioritize liquidity over expansion, potentially limiting future scalability in a rapidly evolving industry.

Balance Sheet And Financial Health

TruBridge’s balance sheet shows $12.3 million in cash against $174.8 million in total debt, indicating a leveraged position. The debt burden may constrain financial flexibility, though the positive operating cash flow provides some cushion. Shareholders’ equity is likely under pressure given the net loss, warranting close monitoring of covenant compliance and refinancing risks.

Growth Trends And Dividend Policy

Revenue stability suggests resilience, but the lack of profitability and no dividend payments reflect a focus on preserving capital. Growth trends appear muted, with limited capex signaling organic expansion challenges. The company may need strategic acquisitions or product innovation to reignite top-line momentum in a competitive market.

Valuation And Market Expectations

The negative EPS and high debt load likely weigh on valuation multiples. Market expectations seem tempered, with investors pricing in turnaround risks. A premium would require demonstrated progress toward profitability or debt reduction, neither of which is evident in the current fiscal year.

Strategic Advantages And Outlook

TruBridge’s niche focus on rural healthcare providers offers defensive qualities, but its financial performance raises execution concerns. The outlook hinges on improving operational efficiency and leveraging its specialized expertise to offset industry headwinds. Success will depend on balancing cost discipline with targeted investments in high-potential segments like analytics or cloud-based solutions.

Sources

Company filings (10-K), CIK 0001169445

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount